# Wireframes

## Executive Summary

The **Wireframes** document provides detailed visual mockups of key Uniting Doctors screens and components. These wireframes guide development and ensure consistency across the platform.

---

## Design Principles

### Core Tenets

1. **Clarity Over Cleverness**: Medical information demands clarity
2. **Mobile-First**: Busy clinicians access on-the-go
3. **Density with Breathing Room**: Information-rich but not cluttered
4. **Hierarchy by Importance**: Evidence level, verification, reputation
5. **Accessibility Built-In**: WCAG 2.1 AA minimum

---

## Component Library

### A. Post Card Component

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ‘¤ CardiologyExpert2024  âš•ï¸ Verified: Cardiology            â”‚
â”‚  ğŸ’ Trusted Expert (1,240 rep)  â€¢  2 hours ago              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  Novel approach to refractory AFib in ICU patients           â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•     â”‚
â”‚                                                              â”‚
â”‚  We've had success with early amiodarone + beta-blocker      â”‚
â”‚  combo in septic patients with new-onset AFib and RVR.       â”‚
â”‚  Retrospective review of 45 patients showed:                 â”‚
â”‚                                                              â”‚
â”‚  â€¢ 89% converted to NSR within 24h                           â”‚
â”‚  â€¢ No significant bradycardia or hypotension                 â”‚
â”‚  â€¢ Mean HR reduction: 38 bpm                                 â”‚
â”‚                                                              â”‚
â”‚  Protocol: Amiodarone 150mg over 10min, then...             â”‚
â”‚  [Continue Reading â–¼]                                        â”‚
â”‚                                                              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  ğŸ“Š Evidence: Level 4 (Case Series)                          â”‚
â”‚  ğŸ· #Cardiology  #Critical-Care  #Arrhythmia                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  â¬† 234       ğŸ’¬ 67 comments      ğŸ”– Save      ğŸ“¤ Share       â”‚
â”‚     Upvote                                                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Anatomy**:

- **Header**: User identity, verification, reputation, timestamp
- **Content**: Rich text, truncated with expansion
- **Metadata**: Evidence level, tags
- **Actions**: Vote, comment, save, share

**Responsive Breakpoints**:

- Desktop (>1024px): Full width with sidebar
- Tablet (768-1023px): Stacked layout
- Mobile (<767px): Compact, touch-optimized

---

### B. Comment Thread Component

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ’¬ 67 Comments                                              â”‚
â”‚  Sort by: [Best] [Newest] [Oldest]                           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  â”‚                                                            â”‚
â”‚  â”‚  â–² 89  ğŸ‘¤ EmergencyMD_ICU  âš•ï¸ Verified: EM  â€¢  1h ago     â”‚
â”‚  â”‚                                                            â”‚
â”‚  â”‚  Great protocol! One caution: We've seen increased        â”‚
â”‚  â”‚  bradycardia in patients already on beta-blockers.        â”‚
â”‚  â”‚  Consider holding home BB before starting.                â”‚
â”‚  â”‚                                                            â”‚
â”‚  â”‚  [1] JACC 2019;73(14):1821 (Amiodarone interactions)     â”‚
â”‚  â”‚                                                            â”‚
â”‚  â””â”€ ğŸ“Œ Reply by OP (CardiologyExpert2024)  â€¢  45m ago        â”‚
â”‚     â–² 34                                                      â”‚
â”‚                                                               â”‚
â”‚     Excellent point! We excluded patients on BB >25mg        â”‚
â”‚     metoprolol equivalent. Should've mentioned that.         â”‚
â”‚                                                               â”‚
â”‚     [Reply] [Upvote]                                          â”‚
â”‚                                                               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  â”‚                                                            â”‚
â”‚  â”‚  â–² 45  ğŸ‘¤ PharmacyDoc  âš•ï¸ Verified: Pharmacology â€¢ 30m    â”‚
â”‚  â”‚                                                            â”‚
â”‚  â”‚  From a pharmacy perspective, watch for:                  â”‚
â”‚  â”‚  â€¢ QT prolongation (amio + fluoroquinolones)              â”‚
â”‚  â”‚  â€¢ Drug interactions (amio inhibits CYP450)               â”‚
â”‚  â”‚                                                            â”‚
â”‚  â”‚  [Reply] [Upvote]                                          â”‚
â”‚  â”‚                                                            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  [Load 64 more comments...]                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Features**:

- **Threading**: Visual nesting for replies
- **OP Badge**: Original poster highlighted
- **Collapsible**: Minimize long threads
- **Sorting**: Best (votes), newest, oldest

---

### C. Search Results Component

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”  septic shock vasopressors                        [Search]â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Filters:                                                     â”‚
â”‚  [All Content â–¼]  [Any Specialty â–¼]  [Any Evidence â–¼]       â”‚
â”‚                                                               â”‚
â”‚  Sort: â— Relevance  â—‹ Recent  â—‹ Most Voted                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ”¥ Top Result                                                â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•     â”‚
â”‚                                                               â”‚
â”‚  "Vasopressin vs Norepinephrine in Septic Shock"             â”‚
â”‚  ğŸ‘¤ Critical_Care_MD  âš•ï¸ Verified  â€¢  980 rep  â€¢  3d ago     â”‚
â”‚                                                               â”‚
â”‚  ...VASST trial showed no mortality difference between        â”‚
â”‚  vasopressin and norepinephrine as first-line...             â”‚
â”‚                                                               â”‚
â”‚  ğŸ“Š Evidence: Level 1b (RCT)                                  â”‚
â”‚  â¬† 456  ğŸ’¬ 89  ğŸ· #Critical-Care #Sepsis #Vasopressors        â”‚
â”‚                                                               â”‚
â”‚  [View Full Post]                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ“„ Research Paper                                            â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•     â”‚
â”‚                                                               â”‚
â”‚  "Angiotensin II for Vasodilatory Shock (ATHOS-3)"           â”‚
â”‚  NEJM 2023  â€¢  PMID: 12345678  â€¢  Shared 67 times            â”‚
â”‚                                                               â”‚
â”‚  Angiotensin II improved MAP in refractory shock...           â”‚
â”‚                                                               â”‚
â”‚  ğŸ”— [Read Paper] (Open Access)  ğŸ“Š [View Summary]            â”‚
â”‚                                                               â”‚
â”‚  ğŸ’¬ 34 discussions referencing this paper                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ’¬ Question                                                  â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•     â”‚
â”‚                                                               â”‚
â”‚  "Patient on 4 pressors with pH 6.9 - next steps?"           â”‚
â”‚  Asked 1d ago  â€¢  23 answers  â€¢  âœ“ Accepted answer           â”‚
â”‚                                                               â”‚
â”‚  Top answer: "Consider ECMO evaluation if reversible..."     â”‚
â”‚                                                               â”‚
â”‚  [View Answers]                                               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

[Load More Results...]
```

**Result Types**:

- ğŸ”¥ **Top Result**: Highest relevance
- ğŸ“„ **Research**: Papers, studies
- ğŸ’¬ **Questions**: Q&A threads
- ğŸ“š **Series**: Multi-part content

---

## Key Screens

### 1. Home Feed (Desktop)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â˜°  Uniting Doctors          ğŸ” Search...            ğŸ””(3)  ğŸ‘¤ Profile   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚          â”‚                                                â”‚                â”‚
â”‚  SIDEBAR â”‚                  MAIN FEED                     â”‚   RIGHT PANEL  â”‚
â”‚          â”‚                                                â”‚                â”‚
â”‚  â”€â”€â”€â”€â”€   â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚  ğŸ  Home â”‚  â”‚  [â• Write a post]  [â“ Ask question] â”‚     â”‚   TRENDING     â”‚
â”‚          â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚                â”‚
â”‚  ğŸ” Searchâ”‚                                               â”‚  ğŸ”¥ #1         â”‚
â”‚          â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚  Refractory    â”‚
â”‚  ğŸ“° Feed â”‚  â”‚  ğŸ‘¤ CardiologyExpert2024             â”‚     â”‚  AFib Protocol â”‚
â”‚   â— For  â”‚  â”‚  Novel approach to AFib...           â”‚     â”‚  567 â¬†        â”‚
â”‚     You  â”‚  â”‚  [Post content...]                   â”‚     â”‚                â”‚
â”‚   â—‹ My   â”‚  â”‚  â¬†234  ğŸ’¬67  ğŸ”–Save                  â”‚     â”‚  ğŸ”¥ #2         â”‚
â”‚     Tags â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚  SGLT2 in      â”‚
â”‚   â—‹ Top  â”‚                                               â”‚  HFpEF         â”‚
â”‚          â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚  432 â¬†        â”‚
â”‚  ğŸ“š Seriesâ”‚  â”‚  ğŸ“„ NEJM: "SGLT2 in HFpEF"          â”‚     â”‚                â”‚
â”‚          â”‚  â”‚  Shared by ResearchDoc               â”‚     â”‚  [View All]    â”‚
â”‚  ğŸ”” Notifâ”‚  â”‚  [Research summary...]               â”‚     â”‚                â”‚
â”‚   (3)    â”‚  â”‚  ğŸ”— Read  ğŸ“Š Figures  ğŸ’¬45           â”‚     â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚          â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚   YOUR STATS   â”‚
â”‚  â”€â”€â”€â”€â”€   â”‚                                               â”‚                â”‚
â”‚  MY      â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚  Reputation:   â”‚
â”‚  SPACES  â”‚  â”‚  ğŸ’¬ Question: "Septic shock..."      â”‚     â”‚  1,240         â”‚
â”‚          â”‚  â”‚  Asked by CommunityDoc               â”‚     â”‚  ğŸ“ˆ +45 today  â”‚
â”‚  Cardio  â”‚  â”‚  23 answers â€¢ âœ“ Resolved             â”‚     â”‚                â”‚
â”‚  Criticalâ”‚  â”‚  [View Thread]                       â”‚     â”‚  This Week:    â”‚
â”‚  Care    â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚  â€¢ 12 posts    â”‚
â”‚  [+New]  â”‚                                               â”‚  â€¢ 67 upvotes  â”‚
â”‚          â”‚  [Load More...]                               â”‚  â€¢ 3 answers   â”‚
â”‚  â”€â”€â”€â”€â”€   â”‚                                               â”‚                â”‚
â”‚  TAGS    â”‚                                               â”‚  [View Profile]â”‚
â”‚          â”‚                                               â”‚                â”‚
â”‚  #Sepsis â”‚                                               â”‚   â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚  #AFib   â”‚                                               â”‚   QUICK LINKS  â”‚
â”‚  #SGLT2  â”‚                                               â”‚                â”‚
â”‚  [+More] â”‚                                               â”‚  ğŸ“– Guidelines â”‚
â”‚          â”‚                                               â”‚  ğŸ“ CME        â”‚
â”‚          â”‚                                               â”‚  âš™ï¸ Settings   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Layout**:

- **Sidebar (200px)**: Navigation + tags
- **Main Feed (fluid)**: Content cards
- **Right Panel (300px)**: Trending, stats, quick links

---

### 2. Home Feed (Mobile)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â˜°  Uniting Doctors    ğŸ””(3)â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚  ğŸ” Search...          [ğŸ”] â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  [â• Post]  [â“ Question]    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ‘¤ CardiologyExpert2024    â”‚
â”‚  âš•ï¸ Verified â€¢ 1,240 rep    â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚  Novel approach to AFib...  â”‚
â”‚                             â”‚
â”‚  [Content preview...]       â”‚
â”‚  [Read More â–¼]              â”‚
â”‚                             â”‚
â”‚  ğŸ“Š Evidence: Level 4       â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚  â¬†234  ğŸ’¬67  ğŸ”–  ğŸ“¤         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ“„ NEJM: SGLT2 in HFpEF    â”‚
â”‚  Shared by ResearchDoc      â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚  [Summary...]               â”‚
â”‚  ğŸ”— Read  ğŸ’¬45              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ’¬ Septic shock question   â”‚
â”‚  23 answers â€¢ Resolved      â”‚
â”‚  [View Thread]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ   ğŸ”  ğŸ””  ğŸ‘¤             â”‚
â”‚  Home Search Notif Profile  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Mobile Optimizations**:

- **Bottom Nav**: Thumb-friendly navigation
- **Cards**: Full-width, swipeable
- **Tap Targets**: Minimum 44x44px
- **Load More**: Infinite scroll

---

### 3. Question Page (Desktop)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â˜°  Uniting Doctors          ğŸ” Search...            ğŸ””  ğŸ‘¤ Profile        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                            â”‚
â”‚  ğŸ’¬ Question                                                               â”‚
â”‚                                                                            â”‚
â”‚  45M with atypical chest pain - stress test or CT angio?                   â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•      â”‚
â”‚                                                                            â”‚
â”‚  ğŸ‘¤ CommunityDocMD  âš•ï¸ Verified: Internal Medicine  â€¢  2 hours ago        â”‚
â”‚  ğŸ¥ Community Hospital  â€¢  234 reputation                                  â”‚
â”‚                                                                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                                                            â”‚
â”‚  Patient: 45M, no cardiac history, presents with atypical chest pain      â”‚
â”‚                                                                            â”‚
â”‚  Presentation:                                                             â”‚
â”‚  â€¢ Sharp, positional chest pain x 2 days                                  â”‚
â”‚  â€¢ Worse with deep breathing                                              â”‚
â”‚  â€¢ No radiation, no diaphoresis                                            â”‚
â”‚  â€¢ No significant cardiac risk factors (non-smoker, no DM/HTN)            â”‚
â”‚                                                                            â”‚
â”‚  Workup so far:                                                            â”‚
â”‚  â€¢ EKG: NSR, no ST changes                                                 â”‚
â”‚  â€¢ Troponin: <0.01 (negative x2, 3 hours apart)                           â”‚
â”‚  â€¢ D-dimer: 450 (mildly elevated)                                         â”‚
â”‚  â€¢ Vitals stable, SpO2 99% RA                                              â”‚
â”‚                                                                            â”‚
â”‚  Question: Stress test vs. CCTA vs. discharge with follow-up?             â”‚
â”‚  Local protocol suggests stress test, but wondering if CCTA is better     â”‚
â”‚  given atypical features and low pre-test probability.                     â”‚
â”‚                                                                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                                                            â”‚
â”‚  ğŸ· #Cardiology  #Emergency-Medicine  #Chest-Pain                          â”‚
â”‚                                                                            â”‚
â”‚  â¬† 89        [Follow Question]        [Share]        [Edit]               â”‚
â”‚     Upvote                                                                 â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ’¬ 23 Answers                                                             â”‚
â”‚  Sort by: â— Best  â—‹ Newest  â—‹ Oldest                                      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  âœ“ ACCEPTED ANSWER                                                         â”‚
â”‚  â–² 156  ğŸ‘¤ EmergencyMD89  âš•ï¸ Verified: Emergency Medicine  â€¢  1h ago      â”‚
â”‚         ğŸ† Expert (980 reputation)                                         â”‚
â”‚                                                                            â”‚
â”‚  Given negative troponin, atypical features, and low pre-test probability, â”‚
â”‚  I'd consider PERC rule for PE risk stratification before stress testing:  â”‚
â”‚                                                                            â”‚
â”‚  PERC Rule (all must be NO for PERC negative):                            â”‚
â”‚  â€¢ Age â‰¥50? YES (fails PERC)                                              â”‚
â”‚  â€¢ HR â‰¥100? (need this data)                                              â”‚
â”‚  â€¢ SpO2 <95%? NO                                                          â”‚
â”‚  â€¢ Hemoptysis? (need history)                                             â”‚
â”‚  â€¢ Prior DVT/PE? (need history)                                           â”‚
â”‚  â€¢ Recent surgery/trauma? (need history)                                  â”‚
â”‚  â€¢ Estrogen use? (need history)                                           â”‚
â”‚  â€¢ Unilateral leg swelling? (need exam)                                   â”‚
â”‚                                                                            â”‚
â”‚  If PERC negative â†’ Can consider discharge with outpatient follow-up      â”‚
â”‚  If PERC positive â†’ CT PE protocol given elevated D-dimer                 â”‚
â”‚                                                                            â”‚
â”‚  For cardiac workup: Given atypical features and low pre-test probability, â”‚
â”‚  stress test is reasonable, but CCTA may be more cost-effective and has   â”‚
â”‚  excellent NPV in low-risk patients.                                      â”‚
â”‚                                                                            â”‚
â”‚  References:                                                               â”‚
â”‚  [1] JAMA 2008;299(22):2463 (PERC rule validation)                        â”‚
â”‚  [2] Circulation 2012;125:e1 (Chest pain guidelines)                      â”‚
â”‚  [3] NEJM 2012;367:299 (CCTA in acute chest pain)                         â”‚
â”‚                                                                            â”‚
â”‚  ğŸ“Š Evidence: Level 1a (Guidelines)                                        â”‚
â”‚                                                                            â”‚
â”‚  [Reply]  [Upvote]  [Cite this answer]                                    â”‚
â”‚                                                                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                                                            â”‚
â”‚  ğŸ“Œ Reply by OP (CommunityDocMD)  â€¢  30 minutes ago                        â”‚
â”‚  â–² 34                                                                      â”‚
â”‚                                                                            â”‚
â”‚  Thank you! This is exactly the kind of systematic approach I needed.     â”‚
â”‚  Patient fails PERC (age â‰¥50), so we'll do CT PE protocol.                â”‚
â”‚  Ended up being a small subsegmental PE.                                  â”‚
â”‚                                                                            â”‚
â”‚  [Reply]  [Upvote]                                                         â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â–² 67  ğŸ‘¤ CardiologyExpert  âš•ï¸ Verified: Cardiology  â€¢  45 minutes ago    â”‚
â”‚                                                                            â”‚
â”‚  Adding to the excellent answer above: For the cardiac workup, recent     â”‚
â”‚  2021 ESC guidelines favor CCTA in patients with low-intermediate pre-testâ”‚
â”‚  probability. CCTA has:                                                    â”‚
â”‚                                                                            â”‚
â”‚  â€¢ NPV >95% (excellent rule-out)                                          â”‚
â”‚  â€¢ Identifies non-cardiac causes                                          â”‚
â”‚  â€¢ No radiation with stress test                                          â”‚
â”‚                                                                            â”‚
â”‚  Stress test still reasonable per AHA guidelines, but CCTA increasingly   â”‚
â”‚  preferred in this scenario.                                              â”‚
â”‚                                                                            â”‚
â”‚  [1] Eur Heart J 2021;42:1289 (ESC Chest Pain Guidelines)                â”‚
â”‚                                                                            â”‚
â”‚  [Reply]  [Upvote]                                                         â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

[View 20 more answers...]

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ’¬ Your Answer                                                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ Write your answer here...                                          â”‚   â”‚
â”‚  â”‚                                                                    â”‚   â”‚
â”‚  â”‚ [B] [I] [Link] [Code] [Image] [Reference]                         â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                                            â”‚
â”‚  [Preview]  [Post Answer]                                                  â”‚
â”‚                                                                            â”‚
â”‚  ğŸ’¡ Good answers:                                                          â”‚
â”‚  â€¢ Provide evidence-based recommendations                                  â”‚
â”‚  â€¢ Cite sources when possible                                             â”‚
â”‚  â€¢ Consider different clinical scenarios                                  â”‚
â”‚  â€¢ Acknowledge limitations/uncertainties                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Q&A Features**:

- **Accepted Answer**: Green checkmark, highlighted
- **Threaded Replies**: OP responses highlighted
- **Evidence Tags**: Level displayed per answer
- **Rich Editor**: Formatting, citations, images

---

### 4. Profile Page

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â˜°  Uniting Doctors          ğŸ” Search...            ğŸ””  ğŸ‘¤ Profile        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                                                                            â”‚
â”‚  ğŸ‘¤ CardiologyExpert2024                                                   â”‚
â”‚  âš•ï¸ Verified: Cardiology                                                   â”‚
â”‚  ğŸ’ Trusted Expert                                                         â”‚
â”‚                                                                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                                                            â”‚
â”‚  Reputation: 1,240  ğŸ“ˆ +45 this week                                       â”‚
â”‚  Member since: January 2024                                                â”‚
â”‚                                                                            â”‚
â”‚  Bio:                                                                      â”‚
â”‚  "Interventional cardiologist interested in structural heart disease,      â”‚
â”‚  valvular disorders, and TAVR. Passionate about evidence-based medicine."  â”‚
â”‚                                                                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                                                                            â”‚
â”‚  [Posts: 67]  [Answers: 234]  [Questions: 12]  [Saved: 89]               â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ“Š Activity Summary                                                       â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                            â”‚
â”‚  This Month:                                                               â”‚
â”‚  â€¢ 12 posts published                                                      â”‚
â”‚  â€¢ 67 upvotes received                                                     â”‚
â”‚  â€¢ 3 accepted answers                                                      â”‚
â”‚  â€¢ 234 reputation gained                                                   â”‚
â”‚                                                                            â”‚
â”‚  Top Tags:                                                                 â”‚
â”‚  ğŸ· #Cardiology (45 posts)                                                 â”‚
â”‚  ğŸ· #Heart-Failure (23 posts)                                              â”‚
â”‚  ğŸ· #TAVR (15 posts)                                                       â”‚
â”‚                                                                            â”‚
â”‚  Badges Earned:                                                            â”‚
â”‚  ğŸ… Great Answer (x12)  ğŸ… Educator (x3)  ğŸ… Contributor (x1)              â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ“ Recent Posts                                                           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚
â”‚                                                                            â”‚
â”‚  "Novel approach to refractory AFib..."  â€¢  234 â¬†  â€¢  67 ğŸ’¬  â€¢  2h ago    â”‚
â”‚  "TAVR outcomes in bicuspid aortic valves"  â€¢  156 â¬†  â€¢  45 ğŸ’¬  â€¢  1d ago â”‚
â”‚  "Managing anticoagulation after valve replacement"  â€¢  89 â¬†  â€¢  1w ago   â”‚
â”‚                                                                            â”‚
â”‚  [View All Posts]                                                          â”‚
â”‚                                                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Profile Features**:

- **Anonymous Identity**: No real name
- **Verification Badge**: Specialty displayed
- **Reputation**: Transparent calculation
- **Activity Stats**: Posts, answers, badges
- **Top Tags**: Expertise areas

---

### 5. Moderation Dashboard (Moderator View)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ›¡ï¸ MODERATION DASHBOARD                                                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  QUEUE (24)  â”‚                                                             â”‚
â”‚              â”‚  Report #REP-45782                                          â”‚
â”‚  Reports: 24 â”‚  Type: ğŸš¨ Medical Misinformation                            â”‚
â”‚  Flagged: 8  â”‚  Priority: HIGH (AI Risk: 0.89)                             â”‚
â”‚  Appeals: 3  â”‚                                                             â”‚
â”‚              â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚                                                             â”‚
â”‚  FILTERS     â”‚  Reported Content:                                          â”‚
â”‚              â”‚  ğŸ‘¤ AnonymousDoc789 (120 rep)  â€¢  Posted 3h ago             â”‚
â”‚  â— All       â”‚                                                             â”‚
â”‚  â—‹ High Pri  â”‚  "For Type 1 diabetics experiencing hypoglycemia, try       â”‚
â”‚  â—‹ Misinfo   â”‚  stopping insulin for 24-48 hours to reset glucose..."     â”‚
â”‚  â—‹ Spam      â”‚                                                             â”‚
â”‚  â—‹ Harass    â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â”‚              â”‚                                                             â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€   â”‚  Reporter:                                                  â”‚
â”‚  TOOLS       â”‚  ğŸ‘¤ User #12345 (450 rep)  â€¢  Reported 1h ago               â”‚
â”‚              â”‚                                                             â”‚
â”‚  View Logs   â”‚  Reason: Dangerous medical misinformation                   â”‚
â”‚  Transparencyâ”‚  Note: "Stopping insulin for T1DM is life-threatening"      â”‚
â”‚  Analytics   â”‚                                                             â”‚
â”‚              â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤                                                             â”‚
               â”‚  Context:                                                   â”‚
               â”‚  â€¢ User has 2 previous warnings                             â”‚
               â”‚  â€¢ Similar reports: 2 in past month                         â”‚
               â”‚  â€¢ AI Risk Assessment: HIGH (0.89)                          â”‚
               â”‚    - Recommends stopping life-saving medication             â”‚
               â”‚    - No evidence cited                                      â”‚
               â”‚    - Contradicts standard of care                           â”‚
               â”‚                                                             â”‚
               â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€  â”‚
               â”‚                                                             â”‚
               â”‚  Moderator Actions:                                         â”‚
               â”‚  [Remove Post]  [Warn User]  [Ban User (7 days)]           â”‚
               â”‚  [Dismiss Report]  [Request Peer Review]                   â”‚
               â”‚                                                             â”‚
               â”‚  Add Note (visible to other moderators):                   â”‚
               â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”‚
               â”‚  â”‚                                                       â”‚ â”‚
               â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â”‚
               â”‚                                                             â”‚
               â”‚  [Take Action]                                              â”‚
               â”‚                                                             â”‚
               â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Moderation Tools**:

- **Priority Queue**: AI-ranked by severity
- **Context Panel**: User history, similar reports
- **Action Log**: Audit trail
- **Peer Review**: Complex cases escalated

---

## Mobile App Wireframes

### 6. Mobile Home Feed

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ â˜°  Uniting Doctors     ğŸ””(3)â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  ğŸ” Search medical topics   â”‚
â”‚                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  [â• New Post] [â“ Question] â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  ğŸ‘¤ CardiologyExpert2024    â”‚
â”‚  âš•ï¸ Verified â€¢ 2h ago       â”‚
â”‚                             â”‚
â”‚  Novel AFib approach...     â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚  We've had success with     â”‚
â”‚  early amiodarone combo...  â”‚
â”‚                             â”‚
â”‚  [Read More â–¼]              â”‚
â”‚                             â”‚
â”‚  ğŸ“Š Evidence: Level 4       â”‚
â”‚  ğŸ· #Cardiology #AFib       â”‚
â”‚                             â”‚
â”‚  â–²234  ğŸ’¬67  ğŸ”–  ğŸ“¤         â”‚
â”‚                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  ğŸ“„ NEJM Research           â”‚
â”‚  Shared by ResearchDoc      â”‚
â”‚                             â”‚
â”‚  "SGLT2 in HFpEF..."        â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€     â”‚
â”‚  [Summary...]               â”‚
â”‚                             â”‚
â”‚  ğŸ”— Read  ğŸ’¬45              â”‚
â”‚                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  ğŸ’¬ Question                â”‚
â”‚  CommunityDoc â€¢ 1d ago      â”‚
â”‚                             â”‚
â”‚  "Septic shock on 4         â”‚
â”‚  pressors - next steps?"    â”‚
â”‚                             â”‚
â”‚  23 answers â€¢ âœ“ Solved      â”‚
â”‚                             â”‚
â”‚  [View Answers]             â”‚
â”‚                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  [Load More...]             â”‚
â”‚                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ    ğŸ”   â•   ğŸ””   ğŸ‘¤     â”‚
â”‚ Home Search Post Notif Me   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Mobile Interactions**:

- **Swipe Right**: Upvote
- **Swipe Left**: Save
- **Long Press**: Quick actions menu
- **Pull Down**: Refresh feed

---

### 7. Mobile Question View

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ â† Back              ğŸ””  â‹®   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  ğŸ’¬ Question                â”‚
â”‚                             â”‚
â”‚  45M with atypical chest    â”‚
â”‚  pain - stress vs CT?       â”‚
â”‚  â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•       â”‚
â”‚                             â”‚
â”‚  ğŸ‘¤ CommunityDocMD          â”‚
â”‚  âš•ï¸ IM â€¢ 2h ago â€¢ 234 rep   â”‚
â”‚                             â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                             â”‚
â”‚  Patient: 45M, no cardiac   â”‚
â”‚  history, atypical chest    â”‚
â”‚  pain x 2 days...           â”‚
â”‚                             â”‚
â”‚  [Read Full Question â–¼]     â”‚
â”‚                             â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                             â”‚
â”‚  ğŸ· #Cardiology #EM         â”‚
â”‚  â–²89  [Follow] [Share]      â”‚
â”‚                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  ğŸ’¬ 23 Answers              â”‚
â”‚  Sort: [Best â–¼]             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  âœ“ ACCEPTED                 â”‚
â”‚  â–²156                       â”‚
â”‚  ğŸ‘¤ EmergencyMD89           â”‚
â”‚  âš•ï¸ EM â€¢ 980 rep â€¢ 1h ago   â”‚
â”‚                             â”‚
â”‚  Given negative troponin    â”‚
â”‚  and atypical features,     â”‚
â”‚  consider PERC rule for     â”‚
â”‚  PE risk...                 â”‚
â”‚                             â”‚
â”‚  [Read Full Answer â–¼]       â”‚
â”‚                             â”‚
â”‚  ğŸ“š 3 references cited       â”‚
â”‚                             â”‚
â”‚  [Reply] [Upvote] [Cite]    â”‚
â”‚                             â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚                             â”‚
â”‚  ğŸ“Œ OP Reply:               â”‚
â”‚  Thank you! CT PE showed    â”‚
â”‚  subsegmental PE.           â”‚
â”‚                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  â–²67  ğŸ‘¤ CardiologyExpert   â”‚
â”‚  Adding to above: ESC       â”‚
â”‚  guidelines favor CCTA...   â”‚
â”‚  [Read More â–¼]              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                             â”‚
â”‚  [View 20 more answers...]  â”‚
â”‚                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  ğŸ’¬ Your Answer             â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚
â”‚  [Write answer...]          â”‚
â”‚                             â”‚
â”‚  [B] [I] [Link] [Ref]       â”‚
â”‚  [Post Answer]              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Design Tokens

### Colors

```css
/* Primary Palette */
--color-primary: #1e40af; /* Medical Blue */
--color-primary-light: #3b82f6;
--color-primary-dark: #1e3a8a;

/* Semantic Colors */
--color-success: #10b981; /* Green - Verified */
--color-warning: #f59e0b; /* Amber - Caution */
--color-danger: #ef4444; /* Red - Error/Danger */
--color-info: #3b82f6; /* Blue - Info */

/* Reputation Tiers */
--color-rep-bronze: #cd7f32;
--color-rep-silver: #c0c0c0;
--color-rep-gold: #ffd700;
--color-rep-diamond: #b9f2ff;

/* Evidence Levels */
--color-evidence-1a: #10b981; /* Strong */
--color-evidence-2: #3b82f6; /* Moderate */
--color-evidence-3: #f59e0b; /* Weak */
--color-evidence-4: #9ca3af; /* Very weak */

/* Neutral Palette */
--color-text-primary: #1f2937;
--color-text-secondary: #6b7280;
--color-text-tertiary: #9ca3af;
--color-bg-primary: #ffffff;
--color-bg-secondary: #f9fafb;
--color-bg-tertiary: #f3f4f6;
--color-border: #e5e7eb;
```

### Typography

```css
/* Font Families */
--font-primary:
  'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
--font-mono: 'JetBrains Mono', 'Courier New', monospace;

/* Font Sizes */
--text-xs: 0.75rem; /* 12px */
--text-sm: 0.875rem; /* 14px */
--text-base: 1rem; /* 16px */
--text-lg: 1.125rem; /* 18px */
--text-xl: 1.25rem; /* 20px */
--text-2xl: 1.5rem; /* 24px */
--text-3xl: 1.875rem; /* 30px */
--text-4xl: 2.25rem; /* 36px */

/* Font Weights */
--font-normal: 400;
--font-medium: 500;
--font-semibold: 600;
--font-bold: 700;

/* Line Heights */
--leading-tight: 1.25;
--leading-normal: 1.5;
--leading-relaxed: 1.75;
```

### Spacing

```css
/* Spacing Scale (rem) */
--space-1: 0.25rem; /* 4px */
--space-2: 0.5rem; /* 8px */
--space-3: 0.75rem; /* 12px */
--space-4: 1rem; /* 16px */
--space-5: 1.25rem; /* 20px */
--space-6: 1.5rem; /* 24px */
--space-8: 2rem; /* 32px */
--space-10: 2.5rem; /* 40px */
--space-12: 3rem; /* 48px */
--space-16: 4rem; /* 64px */
```

### Shadows

```css
/* Box Shadows */
--shadow-sm: 0 1px 2px 0 rgb(0 0 0 / 0.05);
--shadow-md: 0 4px 6px -1px rgb(0 0 0 / 0.1);
--shadow-lg: 0 10px 15px -3px rgb(0 0 0 / 0.1);
--shadow-xl: 0 20px 25px -5px rgb(0 0 0 / 0.1);
```

---

## Accessibility Annotations

### Focus States

```css
/* Keyboard focus indicators */
:focus-visible {
  outline: 3px solid var(--color-primary);
  outline-offset: 2px;
}
```

### ARIA Labels

```html
<!-- Navigation -->
<nav aria-label="Main navigation">
  <button aria-label="Open menu" aria-expanded="false">â˜°</button>
</nav>

<!-- Voting -->
<button aria-label="Upvote post (234 votes)" data-votes="234">â¬† 234</button>

<!-- Loading states -->
<div role="status" aria-live="polite">Loading more posts...</div>
```

### Color Contrast

- **Text on Background**: Minimum 4.5:1 (WCAG AA)
- **Large Text**: Minimum 3:1
- **Interactive Elements**: 3:1 contrast with background

---

## Responsive Breakpoints

```css
/* Mobile First Approach */
@media (min-width: 640px) {
  /* sm: tablets */
}
@media (min-width: 768px) {
  /* md: small laptops */
}
@media (min-width: 1024px) {
  /* lg: desktops */
}
@media (min-width: 1280px) {
  /* xl: large desktops */
}
@media (min-width: 1536px) {
  /* 2xl: very large */
}
```

---

## Conclusion

These wireframes provide:

- **Comprehensive Coverage**: All key screens and flows
- **Component Reusability**: Consistent design system
- **Mobile Optimization**: Touch-friendly, responsive
- **Accessibility**: WCAG 2.1 AA compliant
- **Developer Handoff**: Design tokens, spacing, colors

**Implementation**: Next.js 14+ with Tailwind CSS, Radix UI primitives, Framer Motion animations

---

**Document Version**: 1.0
**Last Updated**: November 8, 2025
**Owner**: Design Team
**Related Documents**:

- [USER_FLOWS.md](./USER_FLOWS.md)
- [BRAND_IDENTITY.md](./BRAND_IDENTITY.md)
- [ONBOARDING_EXPERIENCE.md](../operations/ONBOARDING_EXPERIENCE.md)
